Skip to main content
    I

    Immunitybio Inc (IBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.26
    +0.28 (+4.68%)

    Market Cap: $6.40B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Immunitybio Inc (IBRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Immunitybio (IBRX) has a latest price of $6.26 on Nov 17, 2026, 49.6% below its 52-week high of $12.43. Its price rose 201.0% over the past 12 months. The month-end price rose 38.4% over the 10 years through Oct 2026, a compound annual rate of 3.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $32.51 in Feb 2021 and its lowest $1.02 in Jun 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IBRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IBRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 23.0%, and over 6 months it fell 19.3%. The month-end price rose 164.0% over the 3 years through Oct 2026, a compound annual rate of 38.2%.

    PeriodChange
    1 month-25.7%
    3 months-23.0%
    6 months-19.3%
    12 months+201.0%
    12 months, with dividends+201.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+164.0%+38.2%
    5 years+5.9%+1.1%
    10 years+38.4%+3.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 251.7%, and its weakest was 2018, when it fell 74.2%.

    YearCloseChange
    2026 through Oct 2026$8.29+318.7%
    2025$1.98-22.7%
    2024$2.56-49.0%
    2023$5.02-1.0%
    2022$5.07-16.6%
    2021$6.08-54.4%
    2020$13.33+251.7%
    2019$3.79+226.7%
    2018$1.16-74.2%
    2017$4.49-21.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 26.4% below its 50-day average of $8.51 and 21.4% below its 200-day average of $7.97.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.26
    52-week high$12.43-49.6%
    52-week low$1.95+221.0%
    50-day average$8.51-26.4%
    200-day average$7.97-21.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 79.3%.

    MeasureValue
    1-year beta1.40
    Largest fall, 1 year-48.2%
    Largest fall, 3 years-79.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IBRX

    What is IBRX's 1-year price change?

    Immunitybio's price rose 201.0% over the past 12 months. With dividends included, the 12-month total return was 201.0%.

    What is IBRX's 5-year price change?

    Immunitybio's month-end price rose 5.9% over the 5 years through Oct 2026, a compound annual rate of 1.1%. These figures leave out dividends.

    What is IBRX's 52-week high and low?

    Immunitybio's 52-week high is $12.43 and its 52-week low is $1.95. Its latest price of $6.26 on Nov 17, 2026 is 49.6% below the high.

    What is IBRX's beta?

    Immunitybio's 1-year beta against the S&P 500 is 1.40, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.2%.

    Is the IBRX chart free?

    Yes. Advanced Charting for IBRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.